• Flanders Investment & Trade
  • Team Vesalius

Professor dr. Pierre Van Damme is affiliated with the University of Antwerp, one of Flanders’ five universities.

Pierre Van Damme


Prinsstraat 13
2000 Antwerp

He spearheads the Vaccine & Infectious Disease Institute, which functions as the European WHO Collaborating Centre for the control and prevention of infectious diseases.

Van Damme’s main fields of expertise include epidemiology and social medicine. He has authored more than 350 peer-reviewed papers and is on the editorial boards of several scientific journals that focus on the study of vaccines and vaccine-preventable infectious diseases. He has received numerous prestigious awards and is as a highly regarded international expert in his field.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?